Chikako Yamauchi1, Michio Yoshimura2, Kenji Sekiguchi3, Yasushi Hamamoto4, Naomi Nakajima5, Naoko Sanuki6, Etsuyo Ogo7, Masahiko Oguchi5, Shigehira Saji8, Hiroji Iwata9. 1. Department of Radiation Oncology, Shiga General Hospital, 5-4-30 Moriyama, Moriyama-shi, Shiga, 524-8524, Japan. chikay1796@gmail.com. 2. Department of Radiation Oncology and Image-applied Therapy, Kyoto University Graduate School of Medicine, Kyoto, Japan. 3. Department of Radiation Oncology, Sonoda-kai Radiation Oncology Clinic, Tokyo, Japan. 4. Department of Radiology, Ehime University Hospital, Toon, Japan. 5. Radiation Oncology Department, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan. 6. Radiation Therapy Department, Mie Prefectural General Hospital, Yokkaichi, Japan. 7. Department of Radiology, Kurume University School of Medicine, Kurume, Japan. 8. Department of Medical Oncology, Fukushima Medical University, Fukushima, Japan. 9. Department of Breast Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.
Abstract
PURPOSE: The Japanese Breast Cancer Society (JBCS) Clinical Practice Guideline was revised in 2018. This article describes the revise points in the section on radiation therapy (RT). METHODS AND MATERIALS: The JBCS formed task force to update the JBCS Clinical Practice Guideline 2015 edition. Background questions (BQs) deal with standard treatments of breast cancer in clinical practice. Clinical questions (CQs) highlight the important treatments in which controversy remains. The task force for RT section addressed the 10 BQs, the 10 CQs, and the 4 Future reseach questions (FQs). For each CQ, systematic literature reviews and meta-analyses were conducted, and recommendations, strength of recommendation and strength of evidence were determined according to the protocol in Morizane et al. (Minds Handbook for Clinical Practice Guideline Development, 2014). RESULTS: The recommendations, the strength of recommendation and the strength of evidence were determined based on the systematic literature reviews and the meta-analyses for each CQ. CONCLUSION: The JBCS updated the Clinical Practice Guideline. RT represents a significant portion of the breast cancer treatment, and these recommendations regarding RT will be useful in individualized, shared decision making between physicians and patients.
PURPOSE: The Japanese Breast Cancer Society (JBCS) Clinical Practice Guideline was revised in 2018. This article describes the revise points in the section on radiation therapy (RT). METHODS AND MATERIALS: The JBCS formed task force to update the JBCS Clinical Practice Guideline 2015 edition. Background questions (BQs) deal with standard treatments of breast cancer in clinical practice. Clinical questions (CQs) highlight the important treatments in which controversy remains. The task force for RT section addressed the 10 BQs, the 10 CQs, and the 4 Future reseach questions (FQs). For each CQ, systematic literature reviews and meta-analyses were conducted, and recommendations, strength of recommendation and strength of evidence were determined according to the protocol in Morizane et al. (Minds Handbook for Clinical Practice Guideline Development, 2014). RESULTS: The recommendations, the strength of recommendation and the strength of evidence were determined based on the systematic literature reviews and the meta-analyses for each CQ. CONCLUSION: The JBCS updated the Clinical Practice Guideline. RT represents a significant portion of the breast cancer treatment, and these recommendations regarding RT will be useful in individualized, shared decision making between physicians and patients.